Dr. Reena Jiju Kavilaveettil, MD

Dr. Kavilaveettil practices at St. Mary's Neurology Center in Tampa, Florida.

Dr. Kavilaveettil's NPI, 1629023379, was assigned on May 23, 2006. Dr. Kavilaveettil graduated from Kottayam Medical College in 1998. Dr. Kavilaveettil holds Florida license 9ME0092765.

Dr. Kavilaveettil's primary practice is St. Mary's Neurology Center, at 15267 Amberly Dr, Tampa, FL 33647-2155. The practice phone is (813) 972-5414.

Dr. Kavilaveettil's primary practice is St. Mary's Neurology Center in Tampa, Florida. Dr. Kavilaveettil is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Legacy Healthcare Services. Dmand AI also links Dr. Kavilaveettil to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kavilaveettil practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kavilaveettil's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kavilaveettil is board certified in neurology by the American Board of Physician Specialties (ABPS). Dmand AI has Dr. Kavilaveettil's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Kavilaveettil treats.

CMS data shows 1,087 Medicare services from Dr. Kavilaveettil across 12 procedure codes in 2024, for 399 Medicare patients. Medicare paid $128,715 for them.

CMS counts 399 Medicare patients who saw Dr. Kavilaveettil in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kavilaveettil's median patient age at 70, with 63% women.

In 2024, Dr. Kavilaveettil wrote 4,353 Medicare Part D claims for 612 patients. 87% of them were for generic drugs. CMS names the drug for 4,024 of them, across 90 drugs with 11 or more claims each, at $2,038,426 in total drug cost. In 2023, CMS named 3,309 claims across 81 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kavilaveettil for performance year 2024, reported individually. Dr. Kavilaveettil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kavilaveettil as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Kavilaveettil. The most frequent topics are Biological Transport, Hydrogen-Ion Concentration and Intestinal Absorption.

CMS Open Payments shows 523 general payments to Dr. Kavilaveettil from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Abbott Laboratories paid the most, $2,103.

Dmand AI lists 2 awards for Dr. Kavilaveettil, most recently Best Neurology in 2018. Dr. Kavilaveettil serves on Neuroscience Advent Hospital Tampa.

Dr. Kavilaveettil graduated from Kottayam Medical College in 1998. Dr. Kavilaveettil is a member of National Headache Foundation.

Dr. Kavilaveettil is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.